omeprazole has been researched along with valinomycin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hersey, SJ; Matheravidathu, S; Sachs, G; Steiner, L | 1 |
Asano, S; Iino, T; Tabuchi, Y; Takeguchi, N | 1 |
Blakeman, DP; Im, WB; McGrath, JP; Sih, JC | 1 |
Jackson, R; Lorentzon, P; Sachs, G; Wallmark, B | 1 |
Fallowfield, C; Keeling, DJ; Underwood, AH | 1 |
Bender, AS; White, HS; Woodbury, DM | 1 |
Andersson, K; Bayati, A; Lee, H; Lorentzon, P | 1 |
9 other study(ies) available for omeprazole and valinomycin
Article | Year |
---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Gastric H+-K+-ATPase in situ: relation to secretory state.
Topics: 4-Nitrophenylphosphatase; Adenosine Triphosphatases; Animals; Digitonin; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Imidazoles; Male; Nigericin; Omeprazole; Permeability; Rabbits; Valinomycin | 1988 |
Properties of light and heavy vesicles simultaneously prepared from hog gastric mucosae.
Topics: Adenosine Triphosphatases; Animals; Antibodies, Monoclonal; Cell Fractionation; Electrophoresis, Polyacrylamide Gel; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Imidazoles; Immunochemistry; Omeprazole; Potassium Chloride; Subcellular Fractions; Swine; Valinomycin | 1988 |
Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Aminopyrine; Animals; Benzimidazoles; Cell Membrane; Dose-Response Relationship, Drug; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Male; Omeprazole; Potassium Chloride; Protons; Sulfhydryl Compounds; Swine; Valinomycin | 1985 |
Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.
Topics: 4-Nitrophenylphosphatase; Acridine Orange; Adenosine Triphosphatases; Ammonium Chloride; Animals; Biological Transport, Active; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Mercaptoethanol; Omeprazole; Potassium; Protein Binding; Protons; Stomach; Swine; Valinomycin | 1987 |
The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Biotransformation; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Omeprazole; Phosphorylation; Valinomycin | 1987 |
Ionic dependence of adenosine uptake into cultured astrocytes.
Topics: Adenosine; Animals; Animals, Newborn; Astrocytes; Benzopyrans; Biological Transport; Calcimycin; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Cerebral Cortex; Cromakalim; Furosemide; Glyburide; Ionophores; Kinetics; Mice; Niacinamide; Nicorandil; Nigericin; Omeprazole; Potassium; Pyrroles; Sodium; Valinomycin; Vasodilator Agents | 1994 |
Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Binding Sites; Enzyme Inhibitors; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Humans; Kinetics; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Sulfoxides; Valinomycin | 1997 |